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Peripheral blood monocytes from polar lepromatous leprosy (LL) patients were
unable to support Mycobacterium leprae-induced in vitro lymphoproliferation of
HLA-D-matched T cells from tuberculoid leprosy subjects, whereas those from
responder individuals were able to do so. Monocyte-rich adherent cells from
untreated LL patients released de novo soluble factors which inhibited antigen-
induced lymphoproliferation to a greater extent and mitogenic responses to a
lesser extent. Suppressive activity varied in different LL patients. However, the
degree of suppression was similar in soluble factors obtained de novo and after
treatment of adherent cells with heat-killed and freshly extracted, cryopreserved
M. leprae. Treated patients showed less inhibition with de novo released soluble
factors (27 ± 7.7%) as compared to parallel soluble factors obtained after antigen
treatment (44 ± 4.8%) or with de novo soluble factors from untreated LL patients
(62 ± 14.2%). Similar supernatants from tuberculoid individuals showed no or
insignificant effects on antigen-induced lymphoproliferation. The suppressive
activity ofLL soluble factors was produced for up to 72 h, was heat stable at 56°C
for 30 min, was indomethacin resistant, and resided in the >25,000 molecular
weight fraction.
Adherent cells with macrophage/monocyte
characteristics have been implicated in the im-
munological unresponsiveness associated with a
wide variety of infections. Macrophages alone
or in combination with T cells have been shown
to suppress antibody synthesis and proliferative
responses to specific antigens, mitogens, and
alloantigens in experimental animals infected
with African trypanosomiasis (9), Mycobacte-
rium lepraemurium (4, 36), and Mycobacterium
bovis (12). Peripheral blood-derived monocytes
from patients with tuberculosis (7), sarcoidosis
(11), schistosomiasis (21), disseminated fungal
infection (29), and diffuse cutaneous leishmania-
sis (23) were also reported to inhibit antigen- or
mitogen-induced lymphoproliferation. There is
growing evidence that mycobacteria may cause
suppression of immune responses through the
release of soluble factors from suppressor lym-
phocytes and macrophages (31, 35).
It is well established that Mycobacterium lep-
rae infection leading to disseminated leproma-
tous leprosy is associated with poor T cell
functions. These patients have been consistently
shown to have poor delayed hypersensitivity
reactions and reduced blastogenic and antigenic
responses in vitro (16, 32). In contrast, tubercu-
loid leprosy individuals show optimal responses
in similar assays. The mechanisms underlying
immunological unresponsiveness in lepromatous
leprosy have received recent attention. Having
observed repeatedly that suppressor T cell activ-
ity was not a conspicuous feature in most un-
treated lepromatous individuals studied by us
(17-19, 28) as well as others (5, 27, 30), we
thought it pertinent to investigate the role of
peripheral blood monocytes in this disease, us-
ing a lymphoproliferative assay with enriched T
cell populations.
The present study confirms the earlier find-
ings (19) and indicates that whereas monocytes
from tuberculoid leprosy individuals supported
M. leprae-induced responses of HLA-D identi-
cal responder T-enriched cells, those from lepro-
matous patients were unable to do so. More-
over, monocytes from lepromatous subjects
released soluble factors which inhibited antigen-
and mitogen-induced lymphoproliferation. The
monocyte suppressive factors were released for
up to 3 days of the culture period, were heat
stable, and were not affected by indomethacin
treatment.
MATERUILS AND METHODS
Patients. A total of 63 polar lepromatous and tuber-
culoid leprosy patients were studied. Of these, eight
patients from an endemic area attending the clinics of
Gandhi Memorial Leprosy Foundation, Wardha, In-
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TABLE 1. HLA haplotypes of PBMC of cell donors in monocyte and T cell cocultures
Diag-Expta noSisb Cells HLA haplotypes
la TT T cells AW30, B13, W6, CW6, DRW7/A2, BW40.2 W6, DRW2
TT Monocyte -do-
lb TT T cells A3, BW5, W6, CW3, DRW2/All, BW51, W4, DRW4
TT Monocytes -do-
lc TT T cells AW30, B13, W6, CW6, DRW7/A2, BW40.2, W6, DRW2
TT Monocytes A3, BW5, W6, CW3, DRW2/A1l, BW51, W4, DRW4
ld TT? T cells AW30, B13, W6, CW6, DRW7/A2, BW40.2, W6, DRW2
TT Monocytes -do- (inverse of la)
le TT T cells A3, BW5, W6, CW3, DRW2/A11, BW51, W4, DRW4
TT Monocytes -do- (inverse of lb)
2f TT T cell A2, B40, DRW2/A28, B5, DR2
LL Monocytes A2, B40, DRW2/A28, B7, DRW8
2g TT T cell A28, BW51, W4, CW6, DRW2/AW33, BW53, W4, CW5,
DRW2
LL Monocytes A2, B40, DRW2/A28, B7, DRW8
2h TT T cells AW33, BW40, DRW2, W6/A11, B13, CW2, DRW2, W4
LL Monocytes -do-
a Numbers refer to those in Fig. 1 and 2.
b TT, Tuberculoid; LL, lepromatous.
dia, were selected on the basis of HLA-D identity
between siblings or paired individuals with concordant
and discordant leprosy (Table 1). The data on the HLA
status of these patients was kindly provided by J. J.
van Rood, Department of Immunohematology, Acade-
misch Zeikenhuis, Leiden, The Netherlands, and
N. K. Mehra, Department of Anatomy, All-India In-
stitute of Medical Sciences, New Delhi, and formed
part of earlier reports of De Vries et al. (6). These
patients had received treatment with 100 mg of dap-
sone daily for 3 to 5 years. Lepromatous patients had
residual bacilli in the skin.
The other patients were drawn from the Hansen's
clinics of the All-India Institute of Medical Sciences
and Safdarjang Hospital, New Delhi, and were 28
untreated lepromatous leprosy patients (27 male and 1
female) who were bacillary positive (bacillary index
[24] ranging from 4+ to 6+), 22 untreated tuberculoid
patients (20 male and 2 female), and 5 male leproma-
tous patients treated for 5 to 7 years with dapsone as
described above who had a bacillary index of 1 +. All
patients were graded on the basis of Ridley-Jopling
classification (25), bacillary smears, histopathology of
skin lesions, treatment status, and the level of lympho-
cyte transformation to M. leprae. Percent stimulation
was calculated as the mean counts per minute of
cultures with M. leprae divided by the mean counts
per minute of cultures alone, with the quotient multi-
plied by 100. Peripheral lymphocytes from tuberculoid
patients and three healthy volunteers included in the
study had 356 to 1,820%o antigen-induced stimulation.
Stimulation levels of '100%o were considered negative
and were consistently observed in all lepromatous
patients.
Characterization of cells. T cells were identified by
indirect immunofluorescence using monoclonal anti-
body OKT3 (Orthoclone, Raritan, N.J.). Lympho-
cytes (106) were treated with 50 g.l of a 1:50 dilution of
OKT3 for 45 min at 4°C, washed three times, incubat-
ed with antimouse fluorescein isothiocyanate-conju-
gated antibody F(ab')2 fraction (New England Nuclear
Corp., Boston, Mass.), washed three more times, and
suspended in 10%o glycerol-phosphate-buffered saline
(pH 7.2). Surface immunoglobulin-positive cells were
identified similarly by direct immunofluorescence with
1:40 fluorescein isothiocyanate-conjugated rabbit anti-
human immunoglobulin (immunoglobulin M plus
immunoglobulin G plus immunoglobulin A; Cappel
Laboratories, Cochranville, Pa.). Fluorescence was
visualized by epiillumination with an HBO 50 lamp on
a Zeiss standard immunofluorescence microscope
(Carl Zeiss, Oberkochen, West Germany). Monocytes
were identified by nonspecific esterase staining with a-
naphthyl acetate as the substrate by the method of
Yam et al. (37). Phagocytosis of latex particles (0.3-p.m
in diameter; Sigma Chemical Co., St. Louis, Mo.) was
studied after 106 lymphocytes were incubated with 50
p1 of a 1% latex suspension at 37°C for 30 min.
Stimulants. Stimulants were used at optimal concen-
trations as assessed by earlier studies on lymphoprolif-
eration. Armadillo-derived soluble and integral M.
leprae antigens (AB40) were used at a concentration of
5 p.g of protein per ml and 5 x 106 bacilli per ml and
were a kind gift of R. J. W. Rees, National Institute for
Medical Research, Mill Hill, London, England.
Human-derived M. leprae used for the production of
monocyte factors was isolated from human lepromas
by glass homogenization and used fresh frozen (-20°C
for up to 6 months) and after autoclaving at 15 lb/in2
for 15 min at a concentration of 1.25 x 106 organisms
per 1 x 106 mononuclear cells.
Concanavalin A (Pharmacia Fine Chemicals, Upp-
sala, Sweden) and pokeweed mitogen (GIBCO-Bio-
cult, Irvine, Scotland) were used at concentrations of
100 p.g/ml and 1:250, respectively.
Isolation of subpopulations of PBMC. Peripheral
blood mononuclear cells (PBMC) were isolated from
heparinized (10 to 20 U/ml; preservative-free heparin;
Upjohn and Co., Kalamazoo, Mich.) venous blood of
patients by Ficoll-Hypaque (Pharmacia Fine Chemi-
cals) centrifugation (3). PBMC were washed three
times in Hanks balanced salt solution (GIBCO-Bio-
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cult) and suspended in RPMI 1640 (GIBCO-Biocult)
buffered with 20 mM HEPES (N-2-hydroxyethylpiper-
azine-N'-2-ethanesulfonic acid) (GIBCO-Biocult) and
supplemented with 100 U of penicillin per ml, 100 jig
of streptomycin per ml, and 10% pooled AB serum
(complete medium).
(i) Adherent cells. Adherent cells were isolated from
PBMC on 24-well tissue culture plates (Flow Labora-
tories, Irvine, Scotland) which had been precoated
with fetal calf serum (GIBCO-Biocult). 106 PBMC per
well were incubated for 2 h at 37°C in an atmosphere of
5% CO2 and air. The nonadherent cells were removed
by washing five times with warm Hanks balanced salt
solution. The adherent cells were removed by further
incubating the monolayers with 12 mM xylocaine
(Astra-IDL, Bangalore, India) in RPMI 1640 plus 10%o
fetal calf serum for 45 min at 37°C, washed two times,
and suspended in complete medium.
(ii) Nylon wool column-purified cells. Two-milliliter
syringes were packed with 40 mg of nylon wool
(Leuko-pak; Fenwall Laboratories, Morton Grove,
Ill.), and 10 x 106 nonadherent cells were added to
prewashed, prewarmed columns. The columns were
incubated for a further 1 h at 37°C, and the cells were
removed by dropwise elution with 4 x 1 ml of RPMI
1640 plus 10% fetal calf serum.
MoF(s). Adherent cells obtained from 1 x 106
PBMC per ml per well were overlaid with 1.25 x 106
M. Ieprae and incubated at 37°C for 24 h in a humidi-
fied atmosphere containing 5% CO2 and air. Subse-
quently, supernatants were collected, centrifuged at
400 x g for 5 min, filtered through 0.45-,um mem-
branes (Millipore Corp., Bedford, Mass.), and stored
at -20°C. In the experiments involving time kinetics,
24 h before collection of monocyte factor(s) [MoF(s)]
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adherent cells were washed and replaced with fresh
medium.
Lymphoproliferation assay. (i) HLA-D defined cocul-
tures. Quadruplicates of 105 PBMC and 105 T-enriched
cells in 100 ,ul of complete medium plus 25 pI of 5, 10,
and 20% monocyte-rich adherent cells, respectively,
were set up in round-bottomed microculture plates
(Nunc-intermed, Roskilde, Denmark). They were cul-
tured with and without 25 p.1 of the respective antigens
for 6 days at 37°C in 5% CO2 and air. The cultures
were harvested on glass fiber disks by a semiautomatic
cell harvester (Ilacon, Tonbridge England) 16 h after
the addition of 0.5 p.Ci of methyl-tritiated thymidine
([3H]thymidine; specific activity, 2 Ci/mmol; Amer-
sham International, England). The radioactivity was
counted in an LKB Rackbeta 1I 1215 scintillation
counter.
(ii) MoF(s). Quadruplicate cultures containing 105
PBMC in 50 ,ul of complete medium and 50 ,ul of
MoF(s) with and without 25 RI1 of soluble AB40-
pokeweed mitogen-concanavalin A were set up in
microculture plates. Mitogen- and antigen-stimulated
cultures were harvested on days 3 and 6, respectively,
as described above.
Characterization of factor(s). Indomethacin (Sigma)
was dissolved in 0.1 M Na2CO3 as 20 mg/ml and
diluted in RPMI 1640 to 100 ,ug/ml. Ten micrograms of
indomethacin was added to each well containing
adherent cells derived from 106 PBMC. The cultures
were treated with and without antigen, and superna-
tants were collected as described above.
MoF(s) collected without serum were centrifuged in
Amicon ultrafiltration membrane cones (CFT 25; Ami-
con Corp., Lexington, Mass.) which retained constitu-
ents with a molecular weight above 25,000. The sepa-
I.
Integral Soluble
FIG. 1. Reconstitution of in vitro antigen-induced lymphoproliferative responses of five cocultures in which
10i T-enriched cells from tuberculoid leprosy patients were combined with 5, 10, and 20% monocytes (Mo) from
HLA-D-defined other tuberculoid leprosy individuals and stimulated with integral and soluble M. Ieprae
antigens. Shaded bars indicate PBMC responses of the T cell donor, with mean counts per minute given inside
the bars. The SD was <20%o. Open bars indicate the percent response of the cocultures at the monocyte
concentration shown on the abscissa [percent response = (mean cpm of cultures with antigen/mean cpm of
cultures alone) x 100]. Responses above 100% indicate stimulation in the presence of antigen as compared to
control cultures without antigen. The HLA-D haplotypes of monocytes and T cells for each set of cocultures are
indicated at the tops of the figures.
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FIG. 2. Absence of antigen-induced lymphoproliferation in three cocultures in which 105 T-enriched cells
from tuberculoid leprosy individuals were combined with 5, 10, and 20% monocytes (Mo) from lepromatous
individuals, two of whom shared partial (f and g) and one shared full (h) identity for HLA-D haplotypes, as
indicated at the tops of the figures. Shaded bars indicate PBMC responses of the tuberculoid individuals, with
mean counts per minute given inside the bars. The SD was <20%o. Open bars indicate percent responses (same as
in the legend to Fig. 1) of cocultures at the monocyte concentrations shown on the abscissa. Responses above
100o (- - -) indicate stimulation in the culture with antigen as compared to cultures without antigen.
rated fractions retained within the cone and the filtrate
were made up to the original volume and assayed as
described above.
Expression of results and statistical analysis. (i) HLA-
D cocultures. The counts per minute ± standard devi-
ation (SD) of replicate cultures was calculated, and
percent response was derived as
mean cpm of cultures with antigen
x 100
mean cpm of cultures without antigen
at each concentration of T cells and monocytes.
25 -___--_____--______-
x 20 -
0.
a)2
15
l-I
(ii) MoF(s). The mean counts per minute ± SD of
replicate cultures was calculated, and percent suppres-
sion was expressed as
1 mean cpm of cultures with factor and antigen
[
-
mean cpm of cultures with antigen alone J
x 100
Statistical analysis was done by using Mann-Whit-
ney's U test (1).
Concentration of Mo Factor (l0).
FIG. 3. Dose-related suppressive activity of 10, 25, and 50 ,ul of MoF(s) derived from two lepromatous
patients on soluble M. leprae antigen-induced lymphoproliferative responses of two tuberculoid leprosy patients.
Mean counts per minute ( ) + SD (- - -) of control cultures without addition of factors is indicated. The inset
shows the absence of suppression (bars) on the basal lymphoproliferation (-) of unstimulated PBMC.
Lymphoproliferation in the presence offactors released de novo (M), from monocytes (Mo) treated with heat-
killed M. leprae (El), and from cryopreserved M. leprae (M) is shown.
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RESULTS
M. leprae-induced proliferation of T-enriched
.0 z 8cells in the presence of HLA-D-defined monocytesfrom leprosy patients. To minimize the super-
added effects of allogeneic cell combinations,
.0 -r 4 2 HLA-D-identical cells were used wherever pos-3 ,
r_
Zosible. Nylon wool-purified cells and 2-h adherent
o C4>cells derived from the peripheral blood of differ-O +I +1 ent HLA-D-defined leprosy patients were cocul-
o U >oUtivated in the presence of soluble and integral M.leprae antigens, with [3H]thymidine uptake as
an indicator of proliferation. Nylon wool-puri-
.> fied cells enriched for T cells consisted of 85 toX- 87% OKT3-positive (pan T) cells, <2% surface
immunoglobulin-positive cells, and <1% ester-o X 8 o ase-positive phagocytic cells. The adherent cell
o. E ¢ oopopulation was enriched for monocytes and con-
. U 0 X VI tained 85 to 88% esterase-positive phagocytic2 m < t __
- cells, 5 to 7% OKT3-positive cells, and <3%
Wr o surface immunoglobulin-positive cells. The
C4S.>yield and nature of cells were similar from3E+< +1 +1 +1 tuberculoid and lepromatous subjects. T cells
en 00
-=iofrom tuberculoid leprosy patients and healthy
m . >O responder individuals alone or in combination
C = with 1 and 2% autologous monocytes gave no or
E n X insignificant lymphoproliferation with M. leprae
antigens (data not shown). Cocultures with 5,
C(,,= < = b 10, and 20% monocytes showed antigen-induced
U
. > 8 X > proliferation similar to or higher than the paired
.00. D ocPBMCof the T cell donor.
(i) Stimulation of lymphoproliferation in the
presence of HLA-D-identical monocytes from tu-
o ho< > > g berculoid leprosy patients. Five cocultures were
E:E X undertaken with T cells and monocytes derived
.+1+ +1 ; from paired tuberculoid individuals (Fig. 1). In
X~8w>,,,Qfour cultures, 5% monocytes supported lympho-
^ - v i proliferation to levels similar to or twofold high-UL > o er than the values obtained with unfractionated
E °~~ PBMC. In general, soluble antigen gave highero 3 ° responses than integral antigen. Significant pro-;0 :: s vr='Iliferation was still observable in one coculture in
C4 O >.,which the monocyte concentration was 20%
.u +I +I CO (Fig. la). Proliferation was observable even
. v when T cells and monocytes differed in one
0 > =i < 0 Q D HLA haplotype (Fig. lc and Table 1).S =. a0 (ii) Lack of lymphoproliferation in the presence
4o4 =Eof HLA-D-defined monocytes from lepromatous
0 vED leprosy patients. Of the three cocultures, one
0 2
8- o;4-!MtX shared full and two shared partial HLA-D identi-Q z O oanC, o x ty for T cells and monocytes (Table 1). The T
-2 D = .^mM cells and monocytes were derived from paired
responder tuberculoid leprosy and nonre-
-
t£
.0.0<, osponder lepromatous leprosy individuals, re-
U 2X oc,, 2 ,U U0j spectively. It may be noted from Fig. 2 that0. 0 0.>t_E E o tlunder the conditions as described above, mono-
<.°U 0 OZ8 cytes from lepromatous individuals failed to
F<> X e m X.0 0U induce Tcellproliferation tosolubleandintegral
Oo~Nm so x 4 ! %, A,0M. leprae antigens. In view of the absence ofz proliferation at any concentration of monocytes,
it was not possible to assess whether leproma-
INFECT. IMMUN.894 SATHISH ET AL.
MONOCYTE-DERIVED SUPPRESSOR FACTOR IN LEPROSY 895
z '1
Co 5 l
0
IL
0
z
w
untreated a
C~~~~~~~
0~~~~~~
LEPROMATOUS T'BRCULOID TREATED
LEPROMATOUS
FIG. 4. Overall activity of MoF(s) derived from 12
untreated and 5 treated lepromatous patients and 6
untreated tuberculoid patients on the soluble M. le-
prae antigen-induced lymphoproliferative responses of
tuberculoid individuals.
% suppression =
1 mean cpm of cultures with factor and antigen 1
L mean cpm of cultures with antigen alone J
x 100
Negative values on the ordinate indicate enhance-
ment. Mean percent suppression in the presence of
factors released de novo (0), from monocytes treated
with heat-killed M. leprae (0), and cryopreserved M.
leprae (A) is shown. Mean percent suppression SD
for each group is indicated as t.
tous monocytes were incapable of antigen pre-
sentation or exerted positive suppression.
Effect of MoF(s) on lymphoproliferation. To
explore the possibility that the lack of prolifera-
tion may be due to suppressive MoF(s), adher-
ent cells were left alone or pretreated for 24 h
with heat-killed M. leprae, as well as freshly
extracted bacilli stored at -20°C to preserve
labile antigens. Supernatants from these three
types of cultures were centrifuged to remove
any nonadherent cells, filtered through 0.45-,um
Millipore membranes to remove bacilli, and
stored at -200C. Preliminary studies on the
numbers of esterase-positive adherent cells re-
covered from 106 PBMC of nine lepromatous
and six tuberculoid patients were similar; the
mean + SD of recovered cells was 8.64 ± 1.02 x
104 and 8.79 ± 1.2 x 104, respectively. There-
fore, the MoF(s) obtained from adherent cells of
106 PBMC per well from all leprosy patients
were used at the same concentration for evalua-
tion of suppressive activity. In total, MoF(s)
from 28 untreated, 5 treated lepromatous, and 6
tuberculoid patients were assayed on lympho-
proliferative responses of 3 responder healthy
individuals and 16 tuberculoid patients.
(i) Dose response. Figure 3 shows dose-related
inhibition of antigen-induced lymphoprolifera-
tion of PBMC in cultures containing 10, 25, and
50 ,ul of factors from two lepromatous patients.
The addition of such factors to PBMC alone had
no or an insignificant effect on basal DNA
synthesis (Fig. 3, inset). Suppressive activity
was not observable at 1 and 2 ,ul. In subsequent
assays 50 ,lI of MoF(s) was used.
(ii) Antigen-induced lymphoproliferation.
Monocytes from lepromatous patients consis-
tently released suppressive factors de novo (Ta-
ble 2 and Fig. 4). Significant suppression of
antigen-induced lymphoproliferation ranging
from 37 to 87% was observed in cultures of
PBMC from tuberculoid patients in the presence
of MoF(s) derived from 12 untreated leproma-
tous patients. The addition of either type of
antigens did not significantly enhance the sup-
pressive effect. The percentage of suppression
varied from individual to individual but was
within the same range for all three types of
factors derived from the same patient. Suppres-
sion was observed regardless of the type of M.
leprae antigen used for lymphoproliferation
(data not shown). Interestingly MoF(s) from five
treated lepromatous leprosy patients showed
lower de novo suppressive effects (27 ± 7.7%) as
compared to parallel supematants from antigen-
treated cells (44 ± 4.8%) and de novo factors
from untreated lepromatous leprosy patients (62
± 14.2%) (Fig. 4).
in contrast, similar supernatants derived from
tuberculoid patients showed no suppressive ef-
fects. In some instances such factors had mild
stimulatory effects on antigen-stimulated PBMC
of tuberculoid individuals (Fig. 4 and Table 2)
but none on T cells or nonadherent cells of
lepromatous subjects (data not shown).
Mitogen-induced lymphoproliferation. MoF(s)
derived from nine lepromatous patients also
showed significant suppression of concanavalin
A- and pokeweed mitogen-induced blastogene-
sis of PBMC from healthy individuals (Table 3).
The degree of inhibition was, however, of a
lower order compared to the suppression noted
in antigen-stimulated lymphocyte cultures.
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TABLE 3. Suppression of mitogenic responses of PBMC of three normal healthy individuals in the presence
of monocyte factors [MoF(s)] from nine untreated lepromatous patients
Mean cpm ± SD of mitogen-stimulated PBMC + MoF(s)' (% suppression)
Stimulant No. fCro svdStimulant MoF(s) Nil de novob Heat-killed M. Ieprae Cryopreserved
Concanavalin A 1 32,581 ± 3,252 22,681 ± 3,356 (30) 28,284 ± 1,773 (13) 23,376 ± 2,514 (29)
Concanavalin A 2 32,581 ± 3,252 26,608 ± 5,374 (18) 24,663 ± 4,716 (24) 26,224 ± 2,659 (20)
Concanavalin A 3 32,581 ± 3,252 24,473 ± 3,084 (25) 27,004 ± 1,928 (17) 23,406 ± 2,237 (28)
Pokeweed mitogen 4 8,338 ± 279 6,442 ± 253 (23) ND' ND
Pokeweed mitogen 5 8,338 ± 279 6,571 ± 372 (21) ND ND
Pokeweed mitogen 6 8,338 ± 279 5,534 ± 403 (34) ND ND
Pokeweed mitogen 7 10,605 ± 1,353 8,753 ± 1,064 (17) ND ND
Pokeweed mitogen 8 10,605 ± 1,353 8,609 ± 660 (19) ND ND
Pokeweed mitogen 9 10,605 ± 1,353 8,859 ± 899 (16) ND ND
a MoF(s) released de novo or after treatment of monocytes with M. leprae.
b p < 0.005 as compared to nil.CND, Not done.
Characterization of monocyte suppressive fac-
tors from lepromatous patients. (i) Time kinetics.
It was consistently observed that the 0- to 24-h
supernatants were most suppressive, although
inhibitory effects were detectable in superna-
tants removed from monocytes at 24 to 48 and 48
to 72 h. Factors derived from 15-day-old macro-
phage monolayers failed to produce significant
suppression (Table 4).
(ii) Heat stability. Suppressive activity was
heat stable at 56°C for 30 min (Table 5) and on
immersion in boiling water for 1 min (data not
shown).
(iii) Molecular size. Twenty-four-hour de novo
released MoF(s) from serum-depleted cultures
derived from five lepromatous patients were
centrifuged in ultrafiltration membrane cones
which excluded particles of molecular weight
<25,000 (antigen-treated supernatants were
avoided to preclude the effects, if any, of soluble
antigens leached from prefrozen or heat-killed
M. leprae). It may be observed from Fig. 5 that
the fraction with molecular weight >25,000
showed inhibition of lymphoproliferation to lev-
els observed with unfractionated MoF(s). Frac-
tions below 25,000 were nonsuppressive and
permitted lymphoproliferation to the same order
as that obtained in control antigen-stimulated
PBMC cultures without MoF(s).
(iv) Effect of indomethacin. The addition of
indomethacin, a potent inhibitor of prostaglan-
din synthesis, failed to abrogate the suppressive
effects of MoF(s) from four lepromatous patients
(Fig. 6). Unstimulated control PBMC, when
incubated with similar supernatants, did not
show any alteration in basal DNA synthesis
(Fig. 6, inset).
DISCUSSION
Earlier studies from various laboratories (5,
27, 30), including ours (17-19, 28), had failed to
find a causal relationship between suppressor T
cell activity and the immunological unrespon-
siveness observed in lepromatous leprosy. In
the present study, using cocultures of T-en-
riched and monocyte-rich cell fractions from
HLA-D-defined paired individuals, it was found
that monocytes from lepromatous patients were
unable to support M. leprae-induced lympho-
TABLE 4. Time kinetics of the release of MoF(s) from a lepromatous patient on the soluble M. leprae
antigen-induced lymphoproliferative responses of a tuberculoid leprosy patient"
Mean cpm ± SD of antigen-stimulated PBMC + MoF(s)(%h suppression)Time (h)
Heat-killed Cryopreserved
M. leprae M. Iepraie
0-24 5,958 ± 632 694 ± 131 (88) 834 ± 65 (86) 784 ± 138 (87)
24-48 1,241 ± 198 (80) 1,080 ± 32 (82) 1,061 ± 68 (82)
48-72 2,641 ± 228 (56) 1,841 ± 80 (69) 2,451 ± 65 (59)
72 hrs-15 days 5,729 ± 707 (4) 4,645 ± 391 (23) 4,758 ± 497 (20)
a Twenty-four hours before collection of MoF(s) monocytes were washed and replaced with fresh RPMI 1640,
and MoF(s) were collected de novo or after tratment of monocytes with M. leprae. Supernatants collected on day
15 refer to cultures left uninterrupted after a change of medium at 72 h.
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TABLE 5. Effect of temperature on MoF(s) released de novo from lepromatous leprosy patients
Mean cpm ± SD of antigen-stimulateda PBMC + MoF(s) (% suppression)
No. of
MoF(s) Nil Untreated Heated at 56°C for
30 min
1 5,465 ± 178 1,045 ± 63 (81) 1,321 ± 50 (76)
2 5,465 ± 178 1,211 ± 116 (78) 1,074 ± 84 (80)
3 5,465 ± 178 1,409 ± 403 (74) 1,595 ± 200 (71)
4 7,687 ± 435 2,869 ± 616 (63) 2,661 ± 907 (65)
5 7,687 ± 435 2,752 ± 255 (64) 2,645 ± 201 (66)
6 7,687 ± 435 2,740 ± 407 (64) 2,967 ± 269 (61)
a The antigen used was soluble armadillo-derived M. leprae (AB40).
proliferation of responder individuals, whereas
similar cells from tuberculoid individuals were
able to do so. These results confirm those of our
earlier studies in which HLA-D-identical nonad-
herent cell and adherent cell populations from
siblings with discordant leprosy were investigat-
ed (19). However, neither of these studies dis-
criminated between a defect in antigen-present-
ing capacity and the suppressive ability of
monocytes from lepromatous patients, as no
stimulation was obtained in any of the cultures.
Antigen-related membrane defects (2) and a fail-
ure in antigen presentation of macrophages have
been' postulated by some (10) and refuted by
others (30).
Evidence from our study (15) and other stud-
ies (14, 33) has indicated that macrophages in
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lepromatous dermal granulomas possess abun-
dant Ia antigens, one of the prerequisites consid-
ered to be important for antigen presentation.
Thus, further experiments were designed to
evaluate the suppressive effects of monocytes.
Adherent cells were treated with heat-killed M.
leprae as well as bacilli which had been kept
frozen after fresh extraction to preserve any
labile antigens. Our results indicate that mono-
cytes from lepromatous patients spontaneously
release soluble factors which suppress antigen-
induced lymphoproliferation of tuberculoid pa-
tients. Such supernatants inhibited in vitro mito-
genic responses of healthy individuals to a lesser
degree. In untreated lepromatous leprosy the
suppression exerted by de novo released factors
was of the same order as that exerted by the
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MONOCYTE FACTORS FROM LEPROMATOUS PATIENTS
FIG. 5. Five individual experiments depicting the suppressive activity of MoF(s) in the ultrafiltration fraction
of >25,000 molecular weight. Mean counts per minute ( ) + SD (- - -) of the soluble M. leprae antigen-
induced lymphoproliferation of control PBMC without addition offactors is indicated. Mean counts per minute ±
SD of antigen-stimulated PBMC cultures in the presence of unfractionated (O) and <25,000 molecular weight
(m) and >25,000 molecular weight (El) factors is given as bars.
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antigen-treated monocyte supernatants. The
possibility of intracellular bacilli in the circula-
tion of these patients influencing the production
of suppressive factors cannot be excluded.
However, patients treated for 5 to 7 years who
harbored decreased numbers of residual bacilli
in the skin showed lower suppressive effects,
particularly in the de novo supernatants. Since
all the factors had been filtered through 0.45-,m
Millipore membranes, particulate antigens were
not considered to be contributing to the suppres-
sive activity. Monocytes from tuberculoid lepro-
sy patients treated in a similar manner showed a
conspicuous absence of suppressive factors.
The suppressive activity of the MoF(s) from
lepromatous patients had a molecular weight of
>25,000 and was heat stable, indomethacin re-
sistant, and continuously produced for up to 72
h.
In recent years, MoF(s) have been reported in
guinea pigs and mice infected with Mycobacte-
rium tuberculosis (34) and BCG (31). In the
former experimental model, spontaneous re-
lease of suppressive factors was observed, a
feature similar to ours. Such factors associated
with human adherent cells treated with many
species of mycobacteria, including M. leprae,
have also been shown to inhibit blastogenesis,
protein synthesis, and lymphokine production of
lymphocytes (26, 35).
Monocyte/macrophage factors rich in thymi-
dine (20), arginase (13), interferon (22), and
prostaglandins (8) have been reported to have
suppressive effects on lymphoproliferative re-
sponses. The presence of thymidine and other
low-molecular-weight compounds can be ruled
out in our system, in which suppression was
observed exclusively in the molecular weight
ranges above 25,000. However, our present
studies cannot conclusively rule out either inter-
feron- or prostaglandin-related suppression. Al-
though indomethacin treatment failed to abro-
gate the suppressive effects, the observed de
novo production of suppressive factors could
suggest the possibility of an in vivo induction of
prostaglandin whose effects would not be abro-
gated by the later in vitro addition of indometh-
acin. Similarly, although prostaglandins are low-
molecular-weight compounds, their presence in
micellar form cannot be excluded.
The present results suggest the possibility that
suppressive factors released from the peripheral
blood monocytes of lepromatous patients play a
significant role in the immunological unrespon-
siveness associated with this disease. Whether
the release of these factors is influenced by T
cells, and conversely, whether these factors
function through other suppressive cells re-
quires further elucidation. It would be of consid-
erable importance to determine whether the
INFECT. IMMUN.
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FIG. 6. The absence of indomethacin effect on the
in vitro release of MoF(s) as assayed on the antigen-
induced lymphoproliferation of tuberculoid individ-
uals. Mean counts per minute(m ) ± SD (-- ) of
soluble M. ileprae antigen-stimulated control PBMC
cultured in the absence of MoF(s) is shown at the top
of each figure. The inset shows representative control
PBMC treated with factors and indomethacin in the
absence of antigen. Bars show the suppression of
lymphoproliferation on the addition of de novo factors
released in the presence(MMe) and absence (rm) of
indomethacin as well as factors from monocytes treat-
ed with heat-killed M. Ieprae alone ( p)or in the
presence of indomethacin(Ml).
macrophages in the lesions also release such
suppressive factors and whether this suppres-
sion could be abrogated by immunological ma-
nipulation.
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